Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Biogen
Biogen
Biogen Corporate Event Was COVID Superspreader, Up to 300,000 Related Infections, Study Says
BioSpace
Fri, 12/11/20 - 11:15 am
Biogen
COVID-19
pandemic
superspreaders
conferences
Public Citizen Demands Investigation into "Inappropriate Collaboration" Between FDA and Biogen Over Alzheimer's Drug
BioSpace
Wed, 12/9/20 - 10:59 pm
Biogen
OIG
HHS
aducanumab
Public Citizen
Alzheimer's disease
Is Biogen Getting Desperate?
Motley Fool
Wed, 12/9/20 - 10:42 am
Biogen
SAGE Therapeutics
major depressive disorder
depression
[video+transcript]Here's Why Biotech Deals Are All the Rage Right Now
Motley Fool
Sat, 12/5/20 - 11:24 pm
biotech
M&A
Biogen
SAGE Therapeutics
Eli Lilly
Precision Biosciences
Merck
OncoImmune
Biogen bets $1.5B on Sage's once-failed depression drug
Fierce Biotech
Mon, 11/30/20 - 10:29 am
Biogen
SAGE Therapeutics
zuranolone
depression
Biogen stocks up on Sage's brain drugs in $3B deal
BioPharma Dive
Fri, 11/27/20 - 04:49 pm
Biogen
SAGE Therapeutics
brain diseases
FDA begins review of Samsung Bioepis/Biogen’s Lucentis biosimilar
Pharmaforum
Thu, 11/19/20 - 10:33 am
Novartis
Genentech
Lucentis
biosimilars
Samsung Bioepis
Biogen
FDA
Biogen's Possible Shopping List: 3 Companies the Biotech Might Buy
Motley Fool
Wed, 11/11/20 - 11:01 am
Biogen
M&A
Aurinia
Cassava Sciences
Heron Therapeutics
Biogen ‘continues to work’ with FDA on Alzheimer's drug candidate despite regulatory setback
Biopharma Reporter
Tue, 11/10/20 - 10:36 am
Biogen
FDA
Alzheimer's disease
aducanumab
5 takeaways from the FDA's high-stakes meeting for Biogen's Alzheimer's drug
BioPharma Dive
Mon, 11/9/20 - 08:56 pm
Biogen
FDA
Alzheimer's disease
aducanumab
clinical trials
amyloid
Why Biogen Stock Is Tanking Today
Motley Fool
Mon, 11/9/20 - 11:02 am
Biogen
aducanumab
FDA
Alzheimer's disease
FDA advisers vote against Biogen's Alzheimer's drug, leaving its future in doubt
Biopharma Dive
Fri, 11/6/20 - 08:46 pm
Biogen
aducanumab
FDA
advisory panels
Alzheimer's disease
The FDA's insider review on aducanumab was all about politics, not science, and it threatens patients and the biopharma industry alike
Endpoints
Fri, 11/6/20 - 10:19 am
FDA
Biogen
aducanumab
Alzheimer's disease
FDA scientists appear to offer major endorsement of Biogen’s controversial Alzheimer’s treatment
Stat
Wed, 11/4/20 - 10:50 am
Biogen
aducanumab
Alzheimer's disease
FDA
advisory panels
The meeting that could change Alzheimer's treatment
BioSpace
Tue, 11/3/20 - 09:44 pm
Biogen
aducanumab
Alzheimer's disease
FDA
Biogen's reprieve as critic recused from aducanumab panel, but analysts still read rejection in the tea leaves
Fierce Biotech
Tue, 11/3/20 - 10:59 am
Biogen
aducanumab
FDA
advisory panel
Alzheimer's disease
2 Fumbles and 1 Gift in Biogen's Latest Earnings Report
Motley Fool
Wed, 10/28/20 - 10:38 am
Biogen
earnings
Spinraza
Aducanumab’s day of reckoning approaches
EP Vantage
Fri, 10/23/20 - 10:29 am
Biogen
earnings
aducanumab
FDA
Alzheimer's disease
Biogen is running out of safety nets
BioPharma Dive
Thu, 10/22/20 - 10:53 am
Biogen
Vumerity
Tecfidera
Spinraza
aducanumab
Biogen finally culls MS dud opicinumab, adds SMA gene therapy to the garbage heap
Fierce Biotech
Wed, 10/21/20 - 10:58 am
Biogen
earnings
opicinumab
MS
SMA
BIIB089
Pages
« first
‹ previous
…
19
20
21
22
23
24
25
26
27
…
next ›
last »